Earnings Feed
Start Free
Home/Insiders/DART KENNETH BRYAN
DK
SEC Insider//CIK 0001331271

DART KENNETH BRYAN

CIK 00013312717 companiesGRAND CAYMAN, E9
SEC Profile

Transactions

50

Companies

7

Filings

12

CIK

0001331271

Recent Transactions

50 trades
  • Sale
    iBio, Inc.$IBIO

    Common Stock

    2020-08-11$2.92/sh−15,864,436→ 8,629,693 total
  • Sale
    iBio, Inc.$IBIO

    Common Stock

    2020-08-10$3.91/sh−7,264,864→ 24,494,129 total
  • Sale
    iBio, Inc.$IBIO

    Common Stock

    2020-08-07$3.83/sh−1,355,604→ 31,758,993 total
  • Conversion
    iBio, Inc.$IBIO

    Common Stock

    2020-08-07$0.20/sh+28,925,000→ 33,114,597 total
  • Conversion
    iBio, Inc.$IBIO

    Series B Preferred Stock

    2020-08-07−5,785→ 0 total
  • Sale
    iBio, Inc.$IBIO

    Common Stock

    2020-08-06$4.18/sh−2,768,137→ 33,114,597 total
  • Sale
    iBio, Inc.$IBIO

    Common Stock

    2020-08-05$4.46/sh−900,000→ 35,882,734 total
  • Sale
    iBio, Inc.$IBIO

    Common Stock

    2020-08-04$4.39/sh−600,000→ 36,782,734 total
  • Other
    Marker Therapeutics, Inc.$MRKR

    Series E-1 Warrant

    2020-06-16−416,667→ 0 total
  • Exercise of In-Money
    Marker Therapeutics, Inc.$MRKR

    Series A-1 Warrant

    2020-02-18−416,667→ 0 total
  • Exercise of In-Money
    Marker Therapeutics, Inc.$MRKR

    Common Stock

    2020-02-18$1.20/sh+416,667→ 4,050,001 total
  • Other
    iBio, Inc.$IBIO

    Preferred Stock

    2019-03-14+1→ 1 total
  • Other
    iBio, Inc.$IBIO

    Preferred Stock

    2019-03-14+1→ 1 total
  • Other
    iBio, Inc.$IBIO

    Preferred Stock

    2019-01-01−1→ 1 total
  • Purchase
    iBio, Inc.$IBIO

    Common Shares

    2018-07-12$0.90/sh+2,200,000→ 8,457,734 total
  • Purchase
    iBio, Inc.$IBIO

    Common Shares

    2018-06-26$0.90/sh+1,683,334→ 6,257,734 total
  • Purchase
    iBio, Inc.$IBIO

    Series B Preferred Shares

    2018-06-26$1000.00/sh+5,785→ 5,785 total
  • Purchase
    Marker Therapeutics, Inc.$MRKR

    Common Stock

    2018-05-14$2.40/sh+1,300,000→ 5,300,002 total
  • Purchase
    iBio, Inc.$IBIO

    Common Stock

    2017-11-30$0.20/sh+12,000,000→ 45,744,000 total
  • Purchase
    Bio Green Med Solution, Inc.$BGMS

    Warrant

    2017-07-19+1→ 1 total
  • Purchase
    Bio Green Med Solution, Inc.$BGMS

    Common Stock

    2017-07-19$2.00/sh+850,000→ 2,167,261 total
  • Purchase
    iBio, Inc.$IBIO

    Preferred Stock

    2017-02-23+1→ 1 total
  • Exercise of In-Money
    Marker Therapeutics, Inc.$MRKR

    Common Stock

    2016-08-10$0.50/sh+5,000,000→ 25,000,000 total
  • Other
    Marker Therapeutics, Inc.$MRKR

    Series F-1 Warrant

    2016-08-10+5,000,000→ 1 total
  • Other
    Marker Therapeutics, Inc.$MRKR

    Common Stock

    2016-08-10+3,000,000→ 28,000,000 total
  • Exercise of In-Money
    Marker Therapeutics, Inc.$MRKR

    Series C-1 Warrant

    2016-08-10−5,000,000→ 0 total
  • Purchase
    iBio, Inc.$IBIO

    Common

    2016-04-07$0.62/sh+6,500,000→ 33,744,000 total
  • Purchase
    iBio, Inc.$IBIO

    Common Stock

    2016-01-25$0.62/sh+3,500,000→ 25,460,000 total
  • Exercise of In-Money
    iBio, Inc.$IBIO

    Warrant

    2016-01-25−1,784,000→ 0 total
  • Exercise of In-Money
    iBio, Inc.$IBIO

    Common Stock

    2016-01-25$0.53/sh+1,784,000→ 27,244,000 total
  • Exercise of In-Money
    Marker Therapeutics, Inc.$MRKR

    Series B-1 Warrant

    2015-09-09−10,000,000→ 0 total
  • Exercise of In-Money
    Marker Therapeutics, Inc.$MRKR

    Common Stock

    2015-09-09$0.20/sh+10,000,000→ 20,000,000 total
  • Exercise of In-Money
    Marker Therapeutics, Inc.$MRKR

    Series C-1 Warrant

    2015-06-16−5,000,000→ 1 total
  • Exercise of In-Money
    Marker Therapeutics, Inc.$MRKR

    Common Stock

    2015-06-16$0.50/sh+5,000,000→ 10,000,000 total
  • Other
    Marker Therapeutics, Inc.$MRKR

    Series C-1 Warrant

    2015-05-28−5,000,000→ 0 total
  • Other
    Marker Therapeutics, Inc.$MRKR

    Series B-1 Warrant

    2015-05-28+10,000,000→ 1 total
  • Other
    Marker Therapeutics, Inc.$MRKR

    Series A-1 Warrant

    2015-05-28−5,000,000→ 0 total
  • Other
    Marker Therapeutics, Inc.$MRKR

    Series B-1 Warrant

    2015-05-28−5,000,000→ 0 total
  • Other
    Marker Therapeutics, Inc.$MRKR

    Series C-1 Warrant

    2015-05-28+10,000,000→ 1 total
  • Other
    Marker Therapeutics, Inc.$MRKR

    Series A-1 Warrant

    2015-05-28+5,000,000→ 1 total
  • Exercise Out-of-Money
    Vericel Corp$VCEL

    Common Stock

    2014-07-09$4.80/sh+362,500→ 787,489 total
  • Exercise Out-of-Money
    Vericel Corp$VCEL

    Warrant (right to buy)

    2014-07-09−362,500→ 0 total
  • Purchase
    CYTOKINETICS INC$CYTK

    Common Stock

    2014-02-25$8.00/sh+500,000→ 2,883,845 total
  • Exercise Out-of-Money
    iBio, Inc.$IBIO

    Warrant (right to buy)

    2013-10-15$0.40/sh−7,500,000→ 0 total
  • Other
    iBio, Inc.$IBIO

    Warrant (right to buy)

    2013-10-15+7,500,000→ 1 total
  • Other
    iBio, Inc.$IBIO

    Warrant (right to buy)

    2013-10-15−7,500,000→ 0 total
  • Exercise Out-of-Money
    iBio, Inc.$IBIO

    Common Stock

    2013-10-15$0.40/sh+7,500,000→ 21,960,000 total
  • Purchase
    iBio, Inc.$IBIO

    Warrants (right to buy)

    2013-04-26+1,784,000→ 1,784,000 total
  • Purchase
    iBio, Inc.$IBIO

    Common Stock

    2013-04-26+4,460,000→ 14,460,000 total
  • Sale
    CIFC Corp.

    Deerfield Triarc Capital Corp.

    2006-05-01$13.34/sh−3,880,000→ 0 total

Companies

7

Recent Filings

12

Address

P. O. BOX 31300

GRAND CAYMAN, E9, KY1-1206

View on SEC.gov